AIPLA Issues Statement on Senator Thom Tillis's Patent Eligibility Restoration Act of 2022 August 3, 2022

Home

In This Section

ARLINGTON, Virginia, August 3, 2022 - The American Intellectual Property Law Association (AIPLA) released the following statement on the Patent Eligibility Restoration Act of 2022 introduced by Senator Thom Tillis (R-NC):  


A patent system that provides certainty and reliability promotes the development and investment in innovation, allowing inventions to come to market and benefit everyone.  The introduction of this bill recognizes there is currently a significant problem challenging our country’s innovation system and the need for legislation to address this problem. We wish to express great appreciation for the tremendous hard work and leadership of Senator Tillis and his staff, and we are grateful for the thoughtful consideration. 


AIPLA President Patrick Coyne said, “More work is needed, yet this is a substantial and positive step.  We look forward to considering the legislation further and we welcome additional discussions of this important issue.” 


###

AIPLA, the American Intellectual Property Law Association, was founded in 1897 to maintain a high standard of professional ethics. AIPLA’s mission includes helping establish and maintain fair and effective laws and policies that stimulate and reward innovation while balancing the public’s interest in healthy competition, reasonable costs, and basic fairness. AIPLA is a national bar association of approximately 13,500 members in private and corporate practice, in government service, and in the academic community.

AIPLA Contact:

Ariella Gordon
Marketing and Communications Manager
AIPLA

Upcoming Events

  • 2026 Patent Prosecution Bootcamp - Arlington, VA

    March 4 to 6, 2026   |   Up to 1235 minutes, including 60 Ethics minutes

  • 2026 Trade Secret Summit

    April 23 to 24, 2026

  • 2026 Advanced Chemical & Biotech Patent Institute

    May 11 to 12, 2026   |   CLE calculations pending

    The Advanced Chemical & Biotech Patent Institute is an in-depth continuing legal education program tailored specifically for experienced patent practitioners in the chemical and biotech fields. This advanced course offers a comprehensive view from both prosecution and litigation perspectives, covering crucial topics relevant to practice in the U.S. and internationally.
  • 2026 Spring Meeting - San Francisco, CA

    May 13 to 15, 2026

    We’re excited to welcome you to the 2026 AIPLA Spring Meeting, where innovation, technology, and intellectual property come together to shape the future. San Francisco is ready for your ideas, energy, and passion for IP!
  • AIPLA 2026 Annual Meeting

    October 29 to 31, 2026

    Join us as we bring IP professionals together to learn and connect. More information coming soon! The 2026 Annual meeting will take place at the Westin Washington, DC, Downtown. Leadership Meetings on Wednesday, October 28. Programming scheduled October 29 - 31.